Skip to main content
Application Note

Characterization of NISTmAb with microfluidic CE-SDS


Capillary electrophoresis (CE), more specifically CE-SDS, is becoming an increasingly popular and routinely used method for monitoring and documenting critical quality attributes for monoclonal antibodies, due to its automated operation, on-column detection, resolving power, and protein quantification capability. Such characterization is frequently used in the development and manufacture of biopharmaceuticals.

The LabChip® GXII Touch Protein Characterization System features microfluidic CE-SDS (µCE-SDS) technology for analytical characterization of monoclonal antibodies. It offers an automated alternative to traditional SDS-PAGE methods, by streamlining the multiple, manual steps of slab gel electrophoresis, while providing the throughput and data quality essential to biotherapeutic workflows.

In this application note, the characterization of a reference monoclonal antibody from the National Institute of Standards and Technology (NIST) using the LabChip GXII Touch system is compared to those published by NIST using the SCIEX® PA-800 Plus system.

For research use only. Not for use in diagnostic procedures. 

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Characterization of NISTmAb with microfluidic CE-SDS

Download Application Note